March 12, 2025 – MedLegalNews.com – The U.S. Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA) have finalized a rule expanding access to buprenorphine treatment via telemedicine. This update allows physicians to prescribe schedule III-V controlled substances, including buprenorphine, for opioid use disorder (OUD) treatment—even through audio-only telemedicine encounters. Key […]